Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 15, 2022

View Archived Issues

MKX regulates periodontal ligament homeostasis

HMB-001 bispecific antibody shows promise for treating Glanzmann thrombasthenia

University of Newcastle upon Tyne describes compounds for preventing DNA damage

Ubix Therapeutics presents PROTAC androgen receptor degraders

Dual PI3K-delta/PI3K-gamma inhibitors identified at National Institute of Pharmaceutical R&D Co.

New complement C1s subcomponent inhibitors discovered at Annexon

Mutant SLC6A8 correctors patented by Jnana Therapeutics

Cofilin siRNA, a promising therapy for treatment of hemorrhagic stroke

PSD3 downregulation as new therapeutic strategy against FLD

SETD2 loss promotes tumor metastasis in ccRCC

Studies at CROI show interferons' complex effects, therapeutic potential

Adcentrx and AvantGen partner to discover antibodies for ADC candidates

Therapeutics Solutions reports preclinical data on CampbellCell stem cell therapy for schizophrenia

Novel curcumin derivative, C-0818, inhibits proliferation and induces apoptosis in HCC cells

VDAC1 overexpression tied to ulcerative colitis

Tumor-associated HEVs predict response in melanoma patients receiving anti-PD-1/CTLA-4 combination

Genomic pan-cancer cohort including 25,000 patients identifies organ-specific metastatic patterns

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...